The listing of Kyushu Tong may set off a tide in the field of pharmaceutical business
Release time: 2010-11-03 & nbsp & nbsp & nbsp Source:
The third largest pharmaceutical business enterprise in the country will log in to the Shanghai Stock Exchange Listing Transaction，Stake Sports Bettingstake online sports bettingThe issue price is 13.00 yuan/share，Issuing P / E ratio is 65.00 times。
It is reported，Kyushu Tong is the second pharmaceutical business company in my country with national circulation channels，After the funds raised this time，It may set off a tide of mergers and acquisitions in the field of pharmaceutical business。
It is reported，The number of shares issued by Kyushu this time is 150 million shares，After issuance, the total share capital is 142051.58 10,000 shares，This time I plan to raise a total of funds 89,9.8 million yuan，Among them, the new project of the pharmaceutical logistics center is invested 57,9.8 million，Another 32,000 million yuan will be used to improve the company's financial structure，Supplement the mobile funds required for the company's business expansion。
Kyushu Tong has grown into a business man with national channels，But because it is a private enterprise，Kyushu Tong's development has been restricted by funds in recent years，After the Stake Sports Bettingoverseas My stake betting applisting is unsuccessful，This time, Kyushu Tong's turning to the domestic capital market is expected to get funds faster。
Kyushu Tong is on the market at this time
And due to the flexible management of the company，Once large -scale mergers and acquisitions expand，The status of the second medicine as the second child will be greatly affected。However, in order to keep your own position，It has begun a longer -term plan，It will go to Hong Kong to go public。
Guo Fanli, an analyst at the pharmaceutical industry of China Investment Consultant, said，Kyushu Tong was on the market at this time。Because the state encourages private capital to enter the field of medical circulation。
Current，The draft of the highly anticipated "2010-2015 National Medical Distribution Industry Development Plan" has been completed，Encourage the merger and reorganization of drug circulation enterprises，Encourage the development of retail chain format，Cultivate national level、Local -level leading aircraft stake betting appcarrier stake betting appenterprises，The focus of work in the field of medical circulation during the "Twelfth Five -Year Plan" period。
M & A speed will inevitably increase
And now the entry threshold for drug wholesale enterprises will be greatly improved，Industry mergers and acquisitions will inevitably increase。
Current Chinese Medicine Group、Pharmaceutical Group、Guangzhou Pharmaceutical Group and other state -owned large -scale pharmaceutical companies are looking for and implementing mergers and acquisitions everywhere，At this time, Kyushu Tong joined the merger and acquisition of the army，my country's pharmaceutical business M & A climax is coming。
It is reported，Kyushu Tong is the second pharmaceutical business company in my country with national circulation channels，After the funds raised this time，It may set off a tide of mergers and acquisitions in the field of pharmaceutical business。
It is reported，The number of shares issued by Kyushu this time is 150 million shares，After issuance, the total share capital is 142051.58 10,000 shares，This time I plan to raise a total of funds 89,9.8 million yuan，Among them, the new project of the pharmaceutical logistics center is invested 57,9.8 million，Another 32,000 million yuan will be used to improve the company's financial structure，Supplement the mobile funds required for the company's business expansion。
Kyushu Tong has grown into a business man with national channels，But because it is a private enterprise，Kyushu Tong's development has been restricted by funds in recent years，After the Stake Sports Bettingoverseas My stake betting applisting is unsuccessful，This time, Kyushu Tong's turning to the domestic capital market is expected to get funds faster。
Kyushu Tong is on the market at this time
And due to the flexible management of the company，Once large -scale mergers and acquisitions expand，The status of the second medicine as the second child will be greatly affected。However, in order to keep your own position，It has begun a longer -term plan，It will go to Hong Kong to go public。
Guo Fanli, an analyst at the pharmaceutical industry of China Investment Consultant, said，Kyushu Tong was on the market at this time。Because the state encourages private capital to enter the field of medical circulation。
Current，The draft of the highly anticipated "2010-2015 National Medical Distribution Industry Development Plan" has been completed，Encourage the merger and reorganization of drug circulation enterprises，Encourage the development of retail chain format，Cultivate national level、Local -level leading aircraft stake betting appcarrier stake betting appenterprises，The focus of work in the field of medical circulation during the "Twelfth Five -Year Plan" period。
M & A speed will inevitably increase
And now the entry threshold for drug wholesale enterprises will be greatly improved，Industry mergers and acquisitions will inevitably increase。
Current Chinese Medicine Group、Pharmaceutical Group、Guangzhou Pharmaceutical Group and other state -owned large -scale pharmaceutical companies are looking for and implementing mergers and acquisitions everywhere，At this time, Kyushu Tong joined the merger and acquisition of the army，my country's pharmaceutical business M & A climax is coming。
